Adenocarcinoma of the Prostate
📧 Sign up to get email alerts when something new happens for Adenocarcinoma of the Prostate.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Radiation and Androgen Ablation for Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating the combination of radiation therapy with androgen deprivation for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8) [Phase 1, Phase 2]
Phase 1/2 study of nivolumab with BMS-986253 in hormone-sensitive prostate cancer has posted results. The trial status is active but not rec…
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Study of Histrelin Subdermal Implant in Patients With Prostate Cancer [Phase 3]
Phase 3 clinical trial investigating the histrelin subdermal implant in patients with prostate cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer [Phase 3]
Phase 3 clinical trial evaluating histrelin subdermal implant for advanced prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Intensity Modulated Radiation Therapy (IMRT) Pelvic Nodes Prostate [Phase 1, Phase 2]
Clinical trial updates report on intensity modulated radiation therapy (IMRT) to pelvic nodes for prostate cancer, spanning Phase 1 and Phas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients. [Phase 1, Phase 2]
First-in-man clinical study to evaluate safety and tolerability of an oncolytic adenovirus in prostate cancer patients (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating docetaxel with or without thalidomide in metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-22Clinical Trial Update: Muscadine Plus (MPX) In Men With Prostate Cancer [Phase 3]
Phase 3 clinical trial of Muscadine Plus (MPX) in men with prostate cancer was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating selegiline in combination with docetaxel for metastatic castration-resistant prostate cancer; current stat…
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy [NA]
Pilot study evaluating 18F-DCFPyL PET/CT for assessing men with elevated PSA after radical prostatectomy; study status completed with result…
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: High-Dose Stereotactic Radiation for Prostate Cancer [NA]
A completed clinical trial evaluating high-dose stereotactic radiation for prostate cancer with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Trial of NanoPac® Focal Therapy in Subjects With Prostate Cancer [Phase 2]
Phase 2 trial update for NanoPac focal therapy in prostate adenocarcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: Genistein in Treating Patients With Prostate Cancer [Phase 2]
Phase 2 trial of Genistein in prostate cancer patients has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: Enzalutamide in Patients With High-risk Prostate Cancer [Phase 2]
Phase 2 trial of enzalutamide in high-risk prostate cancer completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2018-08-08Clinical Trial Update: A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC [Phase 2]
Phase 2 trial investigating enzalutamide in combination with AZD5363 for metastatic castration-resistant prostate cancer (mCRPC).
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment [Phase 2]
A Phase 2 study evaluating the combination of docetaxel, estramustine, and short-term androgen withdrawal in patients with rising PSA after …
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating lenalidomide with cyclophosphamide in previously treated hormone-refractory prostate cancer was terminated; res…
-
CLINICAL_TRIALS trial_result · 2018-05-25Clinical Trial Update: Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer [Phase 2]
Phase 2 trial of dasatinib (Sprycel) in hormone-refractory prostate cancer completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating ipilimumab in combination with androgen suppression therapy for metastatic hormone-resistant prostate canc…
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy [Phase 1, Phase 2]
This clinical trial update covers a Phase 1/Phase 2 study for metastatic prostate cancer that is resistant to hormone therapy and chemothera…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Radiation Therapy for Prostate Cancer [NA]
This update notes the completion of a clinical study evaluating high-dose-rate brachytherapy and/or intensity-modulated external beam radiat…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients [Phase 1, Phase 2]
This trial update reports termination of a Phase 1/2 study evaluating Taxotere (docetaxel) with prednisone plus sunitinib in chemotherapy-na…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 trial evaluated combination chemotherapy plus bevacizumab for metastatic prostate cancer and has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-23Clinical Trial Update: Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer [Phase 3]
Phase 3 trial comparing rosiglitazone (Avandia) to placebo in androgen-dependent prostate cancer has completed; trial results are not provid…
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer [Phase 2]
Phase 2 trial investigating lycopene for patients undergoing radical prostatectomy for prostate cancer has completed with results posted.